WAT (Waters) Other Long-Term Liabilities: $158 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAT Waters Corp WAT
96 GF Score
Price $412.76
GF Value $409.80
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Waters Other Long-Term Liabilities?

Waters WAT -0.18% 96 Other Long-Term Liabilities is $158 Mil as of Jun. 2026. GuruFocus rates WAT with a GF Score™ of 96/100 and a GF Value™ of $409.80 (Fairly Valued). The stock has 7 warning signs investors should review.

Waters's other long-term liabilities for the quarter that ended in Jun. 2026 was $158 Mil.

Waters's quarterly other long-term liabilities declined from Dec. 2025 ($198 Mil) to Mar. 2026 ($156 Mil) but then increased from Mar. 2026 ($156 Mil) to Jun. 2026 ($158 Mil).

Waters's annual other long-term liabilities increased from Dec. 2023 ($138 Mil) to Dec. 2024 ($184 Mil) and increased from Dec. 2024 ($184 Mil) to Dec. 2025 ($198 Mil).


Waters Other Long-Term Liabilities Related Terms


Waters Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Waters's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Waters Other Long-Term Liabilities Chart

Waters Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.80 117.54 137.81 183.80 197.82

Waters Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 219.76 204.27 197.82 156.00 158.00
WAT
96GF Score
Waters Corp WAT
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Waters Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $158 Mil mean?
Waters (WAT) has a Other Long-Term Liabilities of $158 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Waters and its competitors.
Is Waters' Other Long-Term Liabilities too high?
Waters' current Other Long-Term Liabilities is $158 Mil. Overall, Waters has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Waters' Other Long-Term Liabilities compare to NTRA and IQV?
Waters' Other Long-Term Liabilities of $158 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Diagnostics & Research company?
A good Other Long-Term Liabilities depends on the Medical Diagnostics & Research industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Waters and its competitors. Waters's current Other Long-Term Liabilities is $158 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Waters stock overvalued right now?
Based on GuruFocus' analysis, Waters (WAT) is currently considered Fairly Valued. The stock's GF Value™ is $409.80, compared to a current price of $412.76 — trading 0.7% above its estimated fair value. The current Other Long-Term Liabilities is $158 Mil. Waters' overall GF Score™ is 96/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Waters (WAT), the current Other Long-Term Liabilities is $158 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Waters (WAT) Overvalued in 2026?

Based on GuruFocus' analysis, Waters stock appears to be overvalued. The current stock price of $412.76 is trading 0.7% above its estimated GF Value™ of $409.80. GuruFocus considers Waters to be Fairly Valued.

Key valuation signals for WAT:

  • Other Long-Term Liabilities: $158 Mil
  • GF Value™: $409.80 vs. price of $412.76 (0.7% above fair value)
  • GF Score™: 96/100 with 7 warning signs

No single metric tells the full story. See the WAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Waters Business Description

Address 34 Maple Street, Milford, MA, USA, 01757
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
96GF Score

Get the complete analysis for WAT

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$412.76
Price
$409.80
GF Value